Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial

被引：0
|
作者：
Xinxin Zhang
Huiyun Zhang
Limei Chen
Mengchang Wang
Jieying Xi
Xin Liu
Ming Xie
Dengzhe Li
Ekamjyot Singh Gulati
Sha Gong
Huaiyu Wang
机构：
[1] First affiliated hospital of Xi’an Jiaotong University,Department of Hematology
来源：
Trials | / 19卷
关键词：
Acute promyelocytic leukemia; Arsenic trioxide; All-trans retinoic acid; Hydroxyurea; Mannitol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy
    Incerpi, MH
    Miller, DA
    Posen, R
    Byrne, JD
    OBSTETRICS AND GYNECOLOGY, 1997, 89 (05): : 826 - 828
  • [42] All-trans retinoic acid:: Treatment and toxicity in acute promyelocytic leukemia
    Ayyildiz, O
    Aybak, M
    Tiftik, N
    Müftüoglu, E
    12TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 2000, : 149 - 153
  • [43] All-trans retinoic acid - Progress in treatment of acute promyelocytic leukemia
    Lengfelder, E
    Hehlmann, R
    ONKOLOGIE, 1997, 20 (02): : 122 - 124
  • [44] Prolonged Arsenic Trioxide (ATO) and All- Trans Retinoic Acid (ATRA) Therapy for Relapsed Acute Promyelocytic Leukemia
    Cicconi, Laura
    Breccia, Massimo
    Franceschini, Luca
    Latagliata, Roberto
    Molica, Matteo
    Rizzo, Manuela
    Divona, Mariadomenica
    Iaccarino, Licia
    Ottone, Tiziana
    Alfonso, Valentina
    Foa, Robin
    Voso, Maria Teresa
    Lo Coco, Francesco
    BLOOD, 2017, 130
  • [45] Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL)
    Wang, Jianxiang
    Mi, Yingchang
    Jiang, Bin
    Chen, Xiequn
    Ji, Chunyan
    Li, Yan
    Zhao, Xielan
    Lai, Yongrong
    Hu, Yu
    Tang, Aiping
    Liu, Ting
    Jin, Jie
    Li, Junmin
    Yang, Linhua
    Li, Jinyong
    Meng, Fanyi
    BLOOD, 2015, 126 (23)
  • [46] Combination therapy with arsenic trioxide (ATO), all-trans retinoic acid (ATRA), and gemtuzumab ozogamycin (GO) in relapsed acute promyelocytic leukemia (APL).
    Aribi, A. M.
    Kantarjian, H.
    Estey, E.
    Freireich, E.
    Koller, C.
    Thomas, D.
    Kornblau, S.
    Faderl, S.
    Laddie, N.
    Garcia-Manero, G.
    Cortes, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 351S - 351S
  • [47] Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome
    Luesink, Maaike
    Pennings, Jeroen L. A.
    Wissink, Willemijn M.
    Linssen, Peter C. M.
    Muus, Petra
    Pfundt, Rolph
    de Witte, Theo J. M.
    van der Reijden, Bert A.
    Jansen, Joop H.
    BLOOD, 2009, 114 (27) : 5512 - 5521
  • [48] Use of all-trans retinoic acid plus arsenic trioxide as alternative to chemotherapy in untreated acute promyelocytic leukemia
    Estey, E.
    ANNALS OF HEMATOLOGY, 2006, 85 : 67 - 68
  • [49] Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
    Estey, E
    Garcia-Manero, G
    Ferrajoli, A
    Faderl, S
    Verstovsek, S
    Jones, D
    Kantarjian, H
    BLOOD, 2006, 107 (09) : 3469 - 3473
  • [50] Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells
    郭为民
    王鸿利
    赵维莅
    诸江
    璩斌
    王学峰
    Chinese Medical Journal, 2001, (01)
12345